U 23 PRO 1 -5.183 -4.702
U 24 THR 8 -8.399 -8.353
U 25 ALA 3 -8.910 -8.231
U 26 CYS 11 -10.940 -10.947
U 27 ARG 9 -10.411 -10.249
U 28 GLU 1 -10.234 -9.172
U 29 LYS 11 -12.320 -12.168
U 30 GLN 14 -14.280 -14.247
U 31 TYR 15 -14.515 -14.571
U 32 LEU 4 -13.573 -12.472
U 33 ILE 20 -13.094 -13.888
U 34 ASN 11 -11.013 -11.012
U 35 SER 3 -10.833 -9.932
U 36 GLN 11 -12.658 -12.467
U 37 CYS 8 -13.736 -13.076
U 38 CYS 23 -16.652 -17.382
U 39 SER 13 -16.077 -15.723
U 40 LEU 17 -15.349 -15.539
U 41 CYS 26 -14.588 -15.900
U 42 GLN 5 -11.325 -10.598
U 43 PRO 7 -9.835 -9.509
U 44 GLY 8 -10.010 -9.779
U 45 GLN 15 -10.861 -11.337
U 46 LYS 14 -12.059 -12.282
U 47 LEU 20 -14.079 -14.760
U 48 VAL 11 -13.752 -13.435
U 49 SER 6 -14.149 -13.212
U 50 ASP 10 -15.605 -14.961
U 51 CYS 23 -16.139 -16.928
U 52 THR 4 -12.418 -11.450
U 53 GLU 0 -11.865 -10.501
U 54 PHE 0 -11.513 -10.189
U 55 THR 9 -12.506 -12.103
U 56 GLU 8 -15.107 -14.289
U 57 THR 25 -16.635 -17.597
U 58 GLU 5 -15.454 -14.252
U 59 CYS 24 -14.657 -15.732
U 60 LEU 12 -11.433 -11.498
U 61 PRO 5 -9.051 -8.585
U 62 CYS 27 -9.423 -11.445
U 63 GLY 10 -6.735 -7.110
U 64 GLU 0 -5.560 -4.921
U 65 SER 4 -7.575 -7.164
U 66 GLU 16 -7.563 -8.533
U 67 PHE 16 -8.507 -9.368
U 68 LEU 21 -10.390 -11.610
U 69 ASP 5 -9.842 -9.285
U 70 THR 9 -9.842 -9.745
U 71 TRP 10 -11.008 -10.892
U 72 ASN 22 -11.993 -13.144
U 73 ARG 15 -13.330 -13.522
U 74 GLU 19 -11.148 -12.051
U 75 THR 5 -10.500 -9.868
U 76 HIS 3 -8.672 -8.020
U 77 CYS 28 -10.364 -12.393
U 78 HIS 19 -7.239 -8.592
U 79 GLN 2 -9.608 -8.733
U 80 HIS 22 -10.486 -11.810
U 81 LYS 24 -11.107 -12.590
U 82 TYR 5 -11.598 -10.840
U 83 CYS 21 -14.634 -15.366
U 84 ASP 8 -12.441 -11.930
U 85 PRO 0 -11.083 -9.808
U 86 ASN 1 -11.297 -10.113
U 87 LEU 18 -15.794 -16.048
U 88 GLY 16 -16.221 -16.196
U 89 LEU 20 -15.885 -16.358
U 90 ARG 9 -13.062 -12.595
U 91 VAL 10 -12.981 -12.638
U 92 GLN 21 -12.272 -13.276
U 93 GLN 8 -10.010 -9.779
U 94 LYS 3 -7.699 -7.158
U 95 GLY 18 -9.415 -10.403
U 96 THR 8 -8.158 -8.140
U 97 SER 13 -7.048 -7.733
U 98 GLU 8 -7.147 -7.245
U 99 THR 9 -9.818 -9.723
U 100 ASP 17 -11.094 -11.773
U 101 THR 21 -11.109 -12.246
U 102 ILE 6 -12.755 -11.978
U 103 CYS 25 -17.341 -18.221
U 104 THR 7 -17.255 -16.076
U 105 CYS 18 -18.358 -18.317
U 106 GLU 11 -14.982 -14.524
U 107 GLU 0 -13.642 -12.073
U 108 GLY 1 -16.572 -14.781
U 109 TRP 21 -19.503 -19.675
U 110 HIS 14 -20.739 -19.964
U 111 CYS 16 -21.907 -21.228
U 112 THR 11 -22.054 -20.783
U 113 SER 5 -19.929 -18.212
U 114 GLU 3 -17.990 -16.267
U 115 ALA 5 -16.902 -15.533
U 116 CYS 22 -20.628 -20.786
U 117 GLU 2 -18.358 -16.477
U 118 SER 5 -19.853 -18.145
U 119 CYS 20 -21.138 -21.007
U 120 VAL 22 -21.825 -21.845
U 121 LEU 7 -19.504 -18.066
U 122 HIS 21 -20.628 -20.670
U 123 ARG 14 -20.719 -19.946
U 124 SER 19 -21.180 -20.929
U 125 CYS 26 -19.628 -20.360
U 126 SER 1 -17.867 -15.927
U 127 PRO 8 -16.269 -15.318
U 128 GLY 1 -14.418 -12.875
U 129 PHE 16 -15.656 -15.696
U 130 GLY 19 -16.282 -16.595
U 131 VAL 17 -15.489 -15.663
U 132 LYS 9 -12.015 -11.668
U 133 GLN 8 -12.272 -11.781
U 134 ILE 5 -15.738 -14.503
U 135 ALA 14 -16.628 -16.326
U 136 THR 2 -13.350 -12.045
U 137 GLY 3 -9.821 -9.037
U 138 VAL 0 -10.141 -8.975
U 139 SER 10 -12.619 -12.318
U 140 ASP 12 -16.259 -15.769
U 141 THR 23 -17.456 -18.093
U 142 ILE 7 -14.518 -13.653
U 143 CYS 20 -14.561 -15.186
U 144 GLU 12 -11.806 -11.828
U 145 PRO 4 -10.989 -10.185
U 146 CYS 27 -13.059 -14.662
U 147 PRO 3 -11.594 -10.606
U 148 VAL 1 -11.593 -10.375
U 149 GLY 13 -12.292 -12.374
U 150 PHE 17 -13.607 -13.997
U 151 PHE 15 -13.631 -13.788
U 152 SER 22 -15.940 -16.637
U 153 ASN 10 -14.550 -14.027
U 154 VAL 12 -18.600 -17.841
U 155 SER 11 -19.775 -18.766
U 156 SER 14 -21.216 -20.387
U 157 ALA 18 -20.093 -19.852
U 158 PHE 3 -17.661 -15.975
U 159 GLU 20 -15.642 -16.143
U 160 LYS 10 -15.350 -14.735
U 161 CYS 25 -14.330 -15.557
U 162 HIS 10 -12.602 -12.303
U 163 PRO 3 -12.667 -11.555
U 164 TRP 24 -12.621 -13.930
U 165 THR 12 -11.023 -11.135
U 166 SER 5 -9.631 -9.098
U 167 CYS 13 -10.005 -10.349
U 168 GLU 0 -8.443 -7.472
U 169 THR 2 -7.924 -7.242
U 170 LYS 11 -9.736 -9.882
U 171 ASP 2 -8.929 -8.132
U 172 LEU 8 -9.994 -9.765
U 173 VAL 5 -9.880 -9.318
U 174 VAL 26 -12.283 -13.860
U 175 GLN 6 -11.919 -11.238
U 176 GLN 24 -12.061 -13.434
U 181 LYS 14 -13.084 -13.189
U 182 THR 9 -12.163 -11.799
U 183 ASP 12 -12.936 -12.829
U 184 VAL 15 -11.921 -12.275
U 185 VAL 4 -10.412 -9.675
U 186 CYS 6 -10.593 -10.065

Identified 0 B-Cell epitope residues out of 160 total residues